Pharmacokinetic, Safety, Tolerability, Immunogenicity, and Pharmacodynamic Study of SB12 in Healthy Subjects
Clinical trial NCT03722329 · COMPLETED
Trial details
- NCT number
- NCT03722329
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2019-03-29
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.